FIELD: medicine.
SUBSTANCE: invention relates to pharmaceutical composition for peroral introduction, which possesses time of release delay, which includes particles containing medication in pharmaceutical composition core; medium layer, which contains two types of water-soluble components: solubility-reducing agent of salting-out or acid type and changed into insoluble form substance of salting-out or acid type; and external layer for regulating rate of water penetration, which contains water-insoluble substance.
EFFECT: invention ensures possibility of temporary defense against insoluble substance dissolving, ensures quick release of medication after definite delay time with possibility to control delay time.
12 cl, 18 dwg, 3 tbl, 31 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS CONTAINING WEAKLY BASIC DRUG SUBSTANCES, AND CONTROLLED-RELEASE DOSAGE FORMS | 2009 |
|
RU2548748C2 |
DRUG DELIVERY COMPOSITION | 2010 |
|
RU2589823C2 |
PER ORALLY DECOMPOSING TABLET COMPOSITIONS, CONTAINING COMBINATIONS OF NON-OPIATE ANALGESICS | 2010 |
|
RU2567032C2 |
COMPOSITION WITH REGULATED MEDICINAL AGENT RELEASING | 1991 |
|
RU2067859C1 |
COMPOSITIONS OF ORALLY DISPERSIBLE TABLETS CONTAINING COMBINATIONS OF HIGH- AND LOW-DOSE THERAPEUTIC AGENTS | 2010 |
|
RU2554740C2 |
PARTICULATE COMPOSITION AND PROCESS FOR OBTAINING IT | 2012 |
|
RU2648353C2 |
CONTROLLED-RELEASE HYDROCODON COMPOSITION | 2001 |
|
RU2253452C2 |
TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS | 2014 |
|
RU2674345C2 |
GASTRORESISTANT PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMIN | 2006 |
|
RU2403015C2 |
IMMEDIATE-ACTION PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2345791C2 |
Authors
Dates
2010-02-27—Published
2005-04-28—Filed